Trial Profile
Early Detection of Pre-malignant and Malignant Conditions in the Colon by Means of Fluorescence Endoscopy Using Local and Oral Sensitisation With Hexaminolevulinate (HAL) - a Dose Finding Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Colorectal cancer
- Focus Diagnostic use
- Sponsors PhotoCure
- 19 Sep 2014 New trial record